These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15966700)

  • 1. Selective embolization in the treatment of intractable epistaxis.
    Andersen PJ; Kjeldsen AD; Nepper-Rasmussen J
    Acta Otolaryngol; 2005 Mar; 125(3):293-7. PubMed ID: 15966700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epistaxis in patients with hereditary hemorrhagic telangiectasia treated with selective arterial embolization.
    Trojanowski P; Jargiello T; Trojanowska A; Klatka J
    Acta Radiol; 2011 Oct; 52(8):846-9. PubMed ID: 21816895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular treatment of epistaxis: indications, management, and outcome.
    Strach K; Schröck A; Wilhelm K; Greschus S; Tschampa H; Möhlenbruch M; Naehle CP; Jakob M; Gerstner AO; Bootz F; Schild HH; Urbach H
    Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1190-8. PubMed ID: 21472510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
    Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
    Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia.
    Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S
    B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu).
    Hanks JE; Hunter D; Goding GS; Boyer HC
    Int Forum Allergy Rhinol; 2014 May; 4(5):422-7. PubMed ID: 24431220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.
    Layton KF; Kallmes DF; Gray LA; Cloft HJ
    AJNR Am J Neuroradiol; 2007 May; 28(5):885-8. PubMed ID: 17494663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A silicone nasal swab for the treatment of severe and recalcitrant epistaxis in hereditary hemorrhagic telangiectasia: an alternative to surgical nostril closure.
    Bruschini L; Seccia V; Dallan I
    Am J Otolaryngol; 2011; 32(4):301-3. PubMed ID: 20719406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous embolization for control of nasal blood circulation.
    Parnes LS; Heeneman H; Vinuela F
    Laryngoscope; 1987 Nov; 97(11):1312-5. PubMed ID: 2823032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous therapeutic embolization in therapy refractory, non-traumatic epistaxis].
    Kramann B; Roth R; Schneider G; Uder M; Federspil P; Iro H
    HNO; 1998 Dec; 46(12):973-9. PubMed ID: 10023591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
    Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
    Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superselective microcoil embolization in severe intractable epistaxis: an analysis of 12 consecutive cases from an otorhinolaryngologic and an interventional neuroradiologic point of view.
    Seidel DU; Remmert S; Brassel F; Schlunz-Hendann M; Meila D
    Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3317-26. PubMed ID: 25502741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endovascular embolization for the treatment of epistaxis: Systematic review and meta-analysis.
    Hoffman H; Ashok Kumar A; Raventhiranathan N; Masoud HE; Gould GC
    Interv Neuroradiol; 2023 Apr; 29(2):172-182. PubMed ID: 35238666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epistaxis-overview and current aspects].
    Thangavelu K; Köhnlein S; Eivazi B; Gurschi M; Stuck BA; Geisthoff U
    HNO; 2021 Nov; 69(11):931-942. PubMed ID: 34643746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epistaxis in Rendu-Osler-Weber disease treated with selective embolization--case report].
    Jarzabek M; Trojanowski P; Szajner M; Pyra K; Sojka M; Szczerbo-Trojanowska M
    Przegl Lek; 2012; 69(7):317-9. PubMed ID: 23276024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management.
    Sautter NB; Smith TL
    Int Forum Allergy Rhinol; 2012; 2(5):422-31. PubMed ID: 22566463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of intractable epistaxis using arterial embolization.
    Scaramuzzi N; Walsh RM; Brennan P; Walsh M
    Clin Otolaryngol Allied Sci; 2001 Aug; 26(4):307-9. PubMed ID: 11559343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).
    Vaiman M; Martinovich U; Eviatar E; Kessler A; Segal S
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):359-63. PubMed ID: 15166924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic embolization for control of epistaxis in a patient with hereditary hemorrhagic telangiectasia.
    Weissman JL; Jungreis CA; Johnson JT
    Am J Otolaryngol; 1995; 16(2):138-40. PubMed ID: 7793510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary haemorrhagic telangiectasia--microembolization in the management of epistaxis.
    Kendall BE; Joyner M; Grant H
    Clin Otolaryngol Allied Sci; 1977 Aug; 2(3):249-61. PubMed ID: 589844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.